Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model.
Alport syndrome (AS) is a genetic disorder marked by mutations in type IV collagen, leading to kidney glomerular dysfunction. AS also involves the cochlea, causing late-onset progressive hearing loss. Currently, there are no therapeutic drugs to protect hearing from AS. HDAC inhibitors (HDACis) are...
Saved in:
Main Authors: | Yoon Seok Nam, Eun-Ji Gi, Yoo-Seung Ko, Sungsu Lee, Hyong-Ho Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0316033 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trichostatin A Promotes the Generation and Suppressive Functions of Regulatory T Cells
by: Cristian Doñas, et al.
Published: (2013-01-01) -
Prevalence of hearing loss and factors associated with hearing loss in Ethiopia: findings from the 2023 National Ethiopia Hearing Survey
by: Tolesa Diriba Biratu, et al.
Published: (2025-01-01) -
Bioinformatics approach reveals the critical role of inflammation-related genes in age-related hearing loss
by: Xi Gu, et al.
Published: (2025-01-01) -
Chitooligosaccharides suppress airway inflammation, fibrosis, and mucus hypersecretion in a house dust mite-induced allergy model
by: Yun-Ho Kim, et al.
Published: (2025-01-01) -
Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease
by: H. Trimarchi, et al.
Published: (2016-01-01)